Journal articles
Carson JM;  Barbieri S;  Cunningham E;  Mao E;  van der Valk M;  Rockstroh JK;  Hellard M;  Kim A;  Bhagani S;  Feld JJ;  Gane E;  Thurnheer MC;  Bruneau J;  Tu E;  Dore GJ;  Matthews GV;  Martinello M, 2023, 'Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study', Journal of the International AIDS Society, 26,  pp. e26168, http://dx.doi.org/10.1002/jia2.26168
Martinello M;  Naggie S;  Rockstroh JK;  Matthews GV, 2023, 'Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review', Clinical Infectious Diseases, 77,  pp. S238 - S244, http://dx.doi.org/10.1093/cid/ciad344
Thompson AJ;  Jackson K;  Bonanzinga S;  Hall SAL;  Hume S;  Burns GS;  Sundararajan V;  Ratnam D;  Levy MT;  Lubel J;  Nicoll AJ;  Strasser SI;  Sievert W;  Desmond PV;  Ngu MC;  Sinclair M;  Meredith C;  Matthews G;  Revill PA;  Littlejohn M;  Bowden DS;  Canchola JA;  Torres J;  Siew P;  Lau J;  Brot BL;  Kuchta A;  Visvanathan K, 2023, 'Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000188
Koopsen J;  Matthews G;  Rockstroh J;  Applegate TL;  Bhagani S;  Rauch A;  Grebely J;  Sacks-Davis R;  Ingiliz P;  Boesecke C;  Rebers S;  Feld J;  Bruneau J;  Martinello M;  Hellard M;  Dore GJ;  Schinkel J;  van der Valk M;  Adams T;  Amjad S;  Appelhans C;  Becker B;  Bouchard R;  Braun D;  Bruelisauer C;  Calcagnile S;  Carroll A;  Cerocchi O;  Chronister K;  Cordes C;  Dore G;  Evans F;  Fedele S;  Ferguson C;  Fraser C;  Ganase B;  Gane E;  George V;  Gerlach C;  Gilleece Y;  Gilliver R;  Grube C;  Gustafson J;  Haas A;  Hagenauer M;  Harris M;  Helder J;  Hirter D;  Hull M;  Katz S;  Kim A;  Kotsoros B;  Lacalamita M;  Lindergard G;  Lutz T;  Macabodbod L;  Manz M;  Marks P;  Messina P;  Mohrmann K;  Monnich C;  Moon J;  Moriggia A;  Morris G;  Morrish T;  Nelson M;  Oliver V;  Patterson J;  Peters M;  Petoumenos K;  Porretta H;  Raymode P;  Read P;  Reece S;  Saidi A;  Sasadeusz J;  Scherler P;  Schröder R;  Selfridge M;  Sevehon A;  Shaw D;  Sulkowski M;  Tamaddoni M;  Thunder O;  Thurnheer MC;  Tu E;  Ustianowski A;  Witele E, 2023, 'Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis', Lancet Microbe, 4,  pp. e622 - e631, http://dx.doi.org/10.1016/S2666-5247(23)00108-8
Cysique LA;  Jakabek D;  Bracken SG;  Allen-Davidian Y;  Heng B;  Chow S;  Dehhaghi M;  Staats Pires A;  Darley DR;  Byrne A;  Phetsouphanh C;  Kelleher A;  Dore GJ;  Matthews GV;  Guillemin GJ;  Brew BJ, 2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10,  pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825
Shah SHBU;  Alavi M;  Hajarizadeh B;  Matthews G;  Valerio H;  Dore GJ, 2023, 'Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets', Journal of Viral Hepatitis, 30,  pp. 520 - 529, http://dx.doi.org/10.1111/jvh.13824
Cheng Q;  Cunningham EB;  Shih S;  Amin J;  Bruneau J;  Artenie AA;  Powis J;  Litwin AH;  Cooper C;  Dalgard O;  Hellard M;  Bruggmann P;  Marks P;  Lacombe K;  Stedman C;  Read P;  Hajarizadeh B;  Dunlop AJ;  Conway B;  Feld JJ;  Dore GJ;  Grebely J;  Dore G;  Crawford S;  Swan T;  Byrne J;  Coordinating Centre—Amanda Erratt ML;  Marks P;  Shaw I;  Siriragavan S;  Quiene S;  Petoumenos K;  Schmid P;  Castro E;  Moriggia A;  Daulouede JP;  Fraser C;  Feld J;  Gane E;  Matthews G;  Kronborg I;  Shaw D;  Norton B;  Thurnheer MC;  Weltman M;  Dillon J;  Kessler S;  Knapp C;  Oprandi L;  Messina P;  Pantic M;  Le Cam M;  Maitre C;  Andreassen J;  Melkeraaen I;  Tollefsen MM;  Pagarigan H;  Milne R;  Mason K;  Kaznowski D;  Zou L;  Bouchard R;  Kotsoros B;  Muir M;  Milloy J;  Oliver V;  Noonan T;  Sevehon A;  Hazelwood S;  Hall M;  Hagenauer M;  Liddle R;  Ferguson C;  Agyemang L;  Patel H;  Soloway I;  Cerocchi O;  Lacalamita M;  Fragomeli V;  Gilliver R;  Lothian R;  Cleary S;  Johnston L;  Middleton S;  D'Amico R;  McGovern B;  Anderson J;  Zhong Z;  Keane F;  Tatsch F;  Brainard D;  McHutchison J, 2023, 'Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs', Value in Health, 26,  pp. 883 - 892, http://dx.doi.org/10.1016/j.jval.2022.12.016
Carson JM;  Barbieri S;  Matthews GV;  Dore GJ;  Hajarizadeh B, 2023, 'Corrigendum to ‘National trends in retreatment of HCV due to reinfection or treatment failure in Australia’ (J Hepatol [2023] 260–270) (Journal of Hepatology (2023) 78(2) (260–270), (S016882782203118X), (10.1016/j.jhep.2022.09.011))', Journal of Hepatology, 78,  pp. 1084, http://dx.doi.org/10.1016/j.jhep.2023.02.020
Akerman A;  Milogiannakis V;  Jean T;  Esneau C;  Silva MR;  Ison T;  Fichter C;  Lopez JA;  Chandra D;  Naing Z;  Caguicla J;  Li D;  Walker G;  Amatayakul-Chantler S;  Roth N;  Manni S;  Hauser T;  Barnes T;  Condylios A;  Yeang M;  Wong M;  Foster CSP;  Sato K;  Lee S;  Song Y;  Mao L;  Sigmund A;  Phu A;  Vande More AM;  Hunt S;  Douglas M;  Caterson I;  Britton W;  Sandgren K;  Bull R;  Lloyd A;  Triccas J;  Tangye S;  Bartlett NW;  Darley D;  Matthews G;  Stark DJ;  Petoumenos K;  Rawlinson WD;  Murrell B;  Brilot F;  Cunningham AL;  Kelleher AD;  Aggarwal A;  Turville SG, 2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', Ebiomedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545
Manoharan L;  Latham NH;  Munari SC;  Traeger MW;  Menon V;  Luhmann N;  Baggaley R;  Macdonald V;  Verster A;  Siegfried N;  Matthews GV;  Stoové M;  Hellard ME;  Doyle JS, 2023, 'Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000082
Carson J;  Barbieri S;  Matthews GV;  Dore GJ;  Hajarizadeh B, 2023, 'Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016-2021', Hepatology Communications, 7,  pp. e0125, http://dx.doi.org/10.1097/HC9.0000000000000125
Isfordink CJ;  Boyd A;  Sacks-Davis R;  van Santen DK;  Smit C;  Martinello M;  Stoove M;  Berenguer J;  Wittkop L;  Klein MB;  Rauch A;  Salmon D;  Lacombe K;  Stewart A;  Schinkel J;  Doyle JS;  Hellard M;  van der Valk M;  Matthews GV, 2023, 'Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study', Lancet Public Health, 8,  pp. e294 - e304, http://dx.doi.org/10.1016/S2468-2667(23)00056-7
Anagnostou N;  Archuleta S;  Athan E;  Barina L;  Best E;  Bloomfield M;  Bostock J;  Botheras C;  Bowen A;  Britton P;  Burden H;  Campbell A;  Carter H;  Cheng M;  Chew KL;  Chong IRLM;  Coombs G;  Daley P;  Daneman N;  Davies J;  Davis J;  Dishon-Benattar Y;  Dotel R;  Dunlop A;  Flack F;  Flanagan K;  Foo H;  Ghanem-Zoubi N;  Giulieri S;  Goodman A;  Grant J;  Gregson D;  Guy S;  Gwee A;  Hardy E;  Henderson A;  Heriot G;  Howden B;  Hudson F;  Johnstone J;  Kalimuddin S;  de Kretser D;  Kwa A;  Lee T;  Legg A;  Lewis R;  Llewelyn M;  Lumley T;  Lye D;  MacFadden D;  Mahar R;  Malhame I;  Marks M;  Marsh J;  Martinello M;  Matthews G;  McArthur C;  McGlothlin A;  McKew G;  McMullan B;  McQuilten Z;  Milliken E;  Mora J;  Morpeth S;  Murthy S;  Nourse C;  O'Sullivan M;  Paterson D;  Paul M;  Petersiel N;  Petrella L;  Pett S;  Price D;  Roberts J;  Robinson JO;  Rogers B;  Saville B;  Scarborough M;  Scheetz M;  Scheuerman O;  Schwartz K;  Smith S;  Snelling T;  Soares M;  Sommerville C;  Stewardson A;  Stone N;  Sud A;  Tilley R;  Tong S;  Turner R;  Underwood J;  van Hal S;  Voss L;  Walls G;  Webb R;  Webb S;  Whiteway L;  Wilson H;  Wuerz T;  Yahav D, 2023, 'The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciac730
Lundgren JD;  Babiker AG;  Sharma S;  Grund B;  Phillips AN;  Matthews G;  Kan VL;  Aagaard B;  Abo I;  Alston B;  Arenas-Pinto A;  Avihingsanon A;  Badal-Faesen S;  Brites C;  Carey C;  Casseb J;  Clarke A;  Collins S;  Corbelli GM;  Dao S;  Denning ET;  Emery S;  Eriobu N;  Florence E;  Furrer H;  Fatkenheuer G;  Gerstoft J;  Gisslen M;  Goodall K;  Henry K;  Horban A;  Hoy J;  Hudson F;  Azwa RISR;  Kedem E;  Kelleher A;  Kityo C;  Klingman K;  La Rosa A;  Leturque N;  Lifson AR;  Losso M;  Lutaakome J;  Madero JS;  Mallon P;  Mansinho K;  El Filali KM;  Molina J-M;  Murray DD;  Nagalingeswaran K;  Nozza S;  Ormaasen V;  Paredes R;  Peireira LC;  Pillay S;  Polizzotto MN;  Raben D;  Rieger A;  Sanchez A;  Schechter M;  Sedlacek D;  Staub T;  Touloumi G;  Turner M;  Madruga JV;  Vjecha M;  Wolff M;  Wood R;  Zilmer K;  Lane HC;  Neaton JD, 2023, 'Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection', NEJM EVIDENCE, 2, http://dx.doi.org/10.1056/EVIDoa2200302
Nyein PP;  Tillakeratne S;  Phyu S;  Yee MM;  Lwin MM;  Htike KL;  Aung MT;  Grebely J;  Applegate T;  Hanson J;  Matthews G;  Lin KS, 2023, 'Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar', Viruses, 15,  pp. 521, http://dx.doi.org/10.3390/v15020521
Carson JM;  Barbieri S;  Matthews GV;  Dore GJ;  Hajarizadeh B, 2023, 'National trends in retreatment of HCV due to reinfection or treatment failure in Australia', Journal of Hepatology, 78,  pp. 260 - 270, http://dx.doi.org/10.1016/j.jhep.2022.09.011
van Santen DK;  Sacks-Davis R;  Stewart A;  Boyd A;  Young J;  van der Valk M;  Smit C;  Rauch A;  Braun DL;  Jarrin I;  Berenguer J;  Lazarus JV;  Lacombe K;  Requena MB;  Wittkop L;  Leleux O;  Salmon D;  Bonnet F;  Matthews G;  Doyle JS;  Spelman T;  Klein MB;  Prins M;  Asselin J;  Stoové MA;  Hellard M, 2023, 'Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019', Eclinicalmedicine, 56, http://dx.doi.org/10.1016/j.eclinm.2022.101810
Schiavone B;  Dore GJ;  Stone E;  Matthews GV;  Darley DR, 2023, 'An update on long COVID and its management', Medicine Today, 24,  pp. 37 - 43
Jessica HB;  Carson J;  Scott M;  Patricia C;  Nelson R;  Helen VG;  Phillip R;  Hanson J;  Robert M;  Matthews G;  Dore GJ;  Martinello M;  Read P, 2023, 'Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C)', Journal of Viral Hepatitis, 30,  pp. 386 - 396, http://dx.doi.org/10.1111/jvh.13803
Hall SAL;  Burns GS;  Mooney BJ;  Millen R;  Morris R;  Vogrin S;  Sundararajan V;  Ratnam D;  Levy MT;  Lubel JS;  Nicoll AJ;  Strasser SI;  Sievert W;  Desmond PV;  Ngu MC;  Angus P;  Sinclair M;  Meredith C;  Matthews G;  Revill PA;  Jackson K;  Littlejohn M;  Bowden S;  Locarnini SA;  Thompson AJ;  Visvanathan K, 2023, 'Hepatitis B Virus Flares after Nucleot(s)ide Analogue Cessation Are Associated with Activation of Toll-Like Receptor Signaling Pathways', Journal of Infectious Diseases, 227,  pp. 123 - 132, http://dx.doi.org/10.1093/infdis/jiac375
Casey JL;  Dore GJ;  Grebely J;  Matthews GV;  Cherepanov V;  Martinello M;  Marks P;  Janssen HLA;  Hansen BE;  Kaul R;  MacParland SA;  Gehring AJ;  Feld JJ, 2023, 'Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection', Journal of Viral Hepatitis, 30,  pp. 64 - 72, http://dx.doi.org/10.1111/jvh.13761
Shah SHBU;  Valerio H;  Hajarizadeh B;  Alavi M;  Matthews G;  Dore G, 2023, 'Cascade of care among people with an HBV notification in New SouthWales, Australia, including diagnosis, specialist assessment, and treatment uptake', JOURNAL OF HEPATOLOGY, 78,  pp. S910 - S910
Phetsouphanh C;  Khoo WH;  Jackson K;  Klemm V;  Howe A;  Aggarwal A;  Akerman A;  Milogiannakis V;  Stella AO;  Rouet R;  Schofield P;  Faulks ML;  Law H;  Danwilai T;  Starr M;  Munier CML;  Christ D;  Singh M;  Croucher PI;  Brilot-Turville F;  Turville S;  Phan TG;  Dore GJ;  Darley D;  Cunningham P;  Matthews GV;  Kelleher AD;  Zaunders JJ, 2022, 'High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells', Frontiers in Immunology, 13,  pp. 1032911, http://dx.doi.org/10.3389/fimmu.2022.1032911
Marshall AD;  Matthews GV, 2022, 'Simplifying hepatitis C care models: a crucial step towards hepatitis C elimination', Lancet Gastroenterology and Hepatology, 7,  pp. 1066 - 1068, http://dx.doi.org/10.1016/S2468-1253(22)00306-5
Carson JM;  Dore GJ;  Lloyd AR;  Grebely J;  Byrne M;  Cunningham E;  Amin J;  Vickerman P;  Martin NK;  Treloar C;  Martinello M;  Matthews GV;  Hajarizadeh B, 2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75,  pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246
Amin J;  Vaccher S;  Templeton DJ;  Bavinton B;  Jin F;  Zablotska I;  Matthews G;  Ogilvie E;  Yeung B;  Ooi C;  Dharan N;  Baker DA;  Read P;  Guy R;  Grulich AE, 2022, 'Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus–Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings from the Expanded PrEP Implementation in Communities–New South Wales Prospective Implementation Study', Clinical Infectious Diseases, 75,  pp. 1497 - 1502, http://dx.doi.org/10.1093/cid/ciac231
Marshall AD;  Martinello M;  Treloar C;  Matthews GV, 2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828
Adhikari A;  Abayasingam A;  Rodrigo C;  Agapiou D;  Pandzic E;  Brasher NA;  Fernando BSM;  Keoshkerian E;  Li H;  Kim HN;  Lord M;  Popovic G;  Rawlinson W;  Mina M;  Post JJ;  Hudson B;  Gilroy N;  Dwyer D;  Sasson SC;  Grubor-Bauk B;  Lloyd AR;  Martinello M;  Bull RA;  Tedla N;  Kaldor J;  Dore G;  Sorrell T;  Bartlett A;  Lemberg D;  Di Girolamo N;  Byrne M;  Hammoud M;  Sultan R;  Konecny P;  Matthews G;  Shek D;  Holdaway S;  Mitsa-Kos K;  How-Chow D;  Lagunday R;  Robinson S;  Terrill L;  Joshi N;  Li Y;  Gill S;  Sevehon A, 2022, 'Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection', Journal of Immunology, 209,  pp. 1499 - 1512, http://dx.doi.org/10.4049/jimmunol.2200272
Aggarwal A;  Akerman A;  Milogiannakis V;  Silva MR;  Walker G;  Stella AO;  Kindinger A;  Angelovich T;  Waring E;  Amatayakul-Chantler S;  Roth N;  Manni S;  Hauser T;  Barnes T;  Condylios A;  Yeang M;  Wong M;  Jean T;  Foster CSP;  Christ D;  Hoppe AC;  Munier ML;  Darley D;  Churchill M;  Stark DJ;  Matthews G;  Rawlinson WD;  Kelleher AD;  Turville SG;  Ruiz Silva M, 2022, 'SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', Ebiomedicine, 84,  pp. 104270, http://dx.doi.org/10.1016/j.ebiom.2022.104270
Rogers AJ;  Wentworth D;  Phillips A;  Shaw-Saliba K;  Dewar RL;  Aggarwal NR;  Babiker AG;  Chang W;  Dharan NJ;  Davey VJ;  Higgs ES;  Gerry N;  Ginde AA;  Hayanga JWA;  Highbarger H;  Highbarger JL;  Jain MK;  Kan V;  Kim K;  Lallemand P;  Leshnower BG;  Lutaakome JK;  Matthews G;  Mourad A;  Mylonakis E;  Natarajan V;  Padilla ML;  Pandit LM;  Paredes R;  Pett S;  Ramachandruni S;  Rehman MT;  Sherman BT;  Files DC;  Brown SM;  Matthay MA;  Thompson BT;  Neaton JD;  Lane HC;  Lundgren JD, 2022, 'The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19', Annals of Internal Medicine, 175,  pp. 1401 - 1410, http://dx.doi.org/10.7326/M22-0924
Holland TL;  Ginde AA;  Paredes R;  Murray TA;  Engen N;  Grandits G;  Vekstein A;  Ivey N;  Mourad A;  Sandkovsky U;  Gottlieb RL;  Berhe M;  Jain MK;  Marines-Price R;  Agbor Agbor BT;  Mateu L;  España-Cueto S;  Lladós G;  Mylonakis E;  Rogers R;  Shehadeh F;  Filbin MR;  Hibbert KA;  Kim K;  Tran T;  Morris PE;  Cassity EP;  Trautner B;  Pandit LM;  Knowlton KU;  Leither L;  Matthay MA;  Rogers AJ;  Drake W;  Jones B;  Poulakou G;  Syrigos KN;  Fernández-Cruz E;  Natale MD;  Almasri E;  Balerdi-Sarasola L;  Bhagani SR;  Boyle KL;  Casey JD;  Chen P;  Douin DJ;  Files DC;  Günthard HF;  Hite RD;  Hyzy RC;  Khan A;  Kibirige M;  Kidega R;  Kiweewa F;  Jensen JU;  Leshnower BG;  Lutaakome JK;  Manian P;  Menon V;  Morales-Rull JL;  O'Mahony DS;  Overcash JS;  Ramachandruni S;  Steingrub JS;  Taha HS;  Waters M;  Young BE;  Phillips AN;  Murray DD;  Jensen TO;  Padilla ML;  Sahner D;  Shaw-Saliba K;  Dewar RL;  Teitelbaum M;  Natarajan V;  Rehman MT;  Pett S;  Hudson F;  Touloumi G;  Brown SM;  Self WH;  Chang CC;  Sánchez A;  Weintrob AC;  Hatlen T;  Grund B;  Sharma S;  Reilly CS;  Garbes P;  Esser MT;  Templeton A;  Babiker AG;  Davey VJ;  Gelijns AC;  Higgs ES;  Kan V;  Matthews G;  Thompson BT;  Neaton JD, 2022, 'Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial', Lancet Respiratory Medicine, 10,  pp. 972 - 984, http://dx.doi.org/10.1016/S2213-2600(22)00215-6
Shah SHBU;  Alavi M;  Hajarizadeh B;  Matthews GV;  Martinello M;  Danta M;  Amin J;  Law MG;  George J;  Valerio H;  Dore GJ, 2022, 'Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales', Jhep Reports, 4, http://dx.doi.org/10.1016/j.jhepr.2022.100552
Douin DJ;  Siegel L;  Grandits G;  Phillips A;  Aggarwal NR;  Baker J;  Brown SM;  Chang CC;  Goodman AL;  Grund B;  Higgs ES;  Hough CL;  Murray DD;  Paredes R;  Parmar M;  Pett S;  Polizzotto MN;  Sandkovsky U;  Self WH;  Young BE;  Babiker AG;  Davey VJ;  Kan V;  Gelijns AC;  Matthews G;  Thompson BT;  Lane HC;  Neaton JD;  Lundgren JD;  Ginde AA;  Meintjes GA;  Armstrong W;  Glidden D;  Maldonado Y;  Murray BE;  Ray SC;  Rolla VC;  Saloojee H;  Tsiatis AA;  Volberding PA;  Kimmelman J;  Hunsberger S, 2022, 'Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery', American Journal of Respiratory and Critical Care Medicine, 206,  pp. 730 - 739, http://dx.doi.org/10.1164/rccm.202112-2836OC
Mylonakis E, 2022, 'Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 A Randomized Controlled Trial', Annals of Internal Medicine, 175,  pp. 1266 - 1274, http://dx.doi.org/10.7326/M22-1503
Bartlett SR;  Verich A;  Carson J;  Hosseini-Hooshyar S;  Read P;  Baker D;  Post JJ;  Finlayson R;  Bloch M;  Doyle JS;  Shaw D;  Hellard M;  Martinez M;  Marks P;  Dore GJ;  Matthews GV;  Applegate T;  Martinello M;  Hosseini Hooshyar S, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
Hernández Cordero AI;  Yang CX;  Yang J;  Li X;  Horvath S;  Shaipanich T;  MacIsaac J;  Lin D;  McEwen L;  Kobor MS;  Guillemi S;  Harris M;  Lam W;  Lam S;  Obeidat M;  Novak RM;  Hudson F;  Klinker H;  Dharan N;  Montaner J;  Man SFP;  Kunisaki K;  Sin DD;  Leung JM;  Baker JV;  Duprez D;  Carr A;  Hoy J;  Dolan M;  Telenti A;  Grady C;  Matthews G;  Rockstroh J;  Belloso WH;  Kagan JM;  Wright E;  Brew B;  Price RW;  Robertson K;  Cysique L;  Connett JE;  Niewoehner DE;  Endpoint Review Committee ;  Lifson A;  Davey RT;  Gatell JM;  Pedersen C;  Prineas R;  Worley J, 2022, 'The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study', Ebiomedicine, 83, http://dx.doi.org/10.1016/j.ebiom.2022.104206
Mylonakis E;  Lutaakome J;  Jain MK;  Rogers AJ;  Moltó J;  Benet S;  Mourad A;  Files DC;  Mugerwa H;  Kityo C;  Kiweewa F;  Nalubega MG;  Kitonsa J;  Nabenkema E;  Murray DD;  Braun D;  Kamel D;  Higgs ES;  Hatlen TJ;  Kan VL;  Sanchez A;  Tierney J;  Denner E;  Wentworth D;  Babiker AG;  Davey VJ;  Gelijns AC;  Matthews GV;  Thompson BT;  Lane HC;  Neaton JD;  Lundgren JD, 2022, 'Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)', Med, 3,  pp. 531 - 537, http://dx.doi.org/10.1016/j.medj.2022.07.003
Papot E;  Jacoby S;  Arlinda D;  Avihingsanon A;  Azwa I;  Borok M;  Brown D;  Cisse M;  Dao S;  Eriobu N;  Kaplan R;  Karyana M;  Kumarasamy N;  Losso MH;  Matthews GV;  Perelis L;  Perez-Casas C;  Ruxrungtham K;  Watkins M;  Lane HC;  Kelleher A;  Law M;  Polizzotto M, 2022, 'Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT', HIV Research & Clinical Practice, 23,  pp. 37 - 46, http://dx.doi.org/10.1080/25787489.2022.2103572
Catlett B;  Starr M;  Machalek DA;  Danwilai T;  Palmer M;  Kelly A;  Kaldor J;  Dore GJ;  Darley D;  Matthews G;  Cunningham PH, 2022, 'Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection: SARS-CoV-2 detection from dried blood spots', Journal of Clinical Virology Plus, 2, http://dx.doi.org/10.1016/j.jcvp.2022.100093
Wheeler A;  Valerio H;  Cunningham EB;  Martinello M;  Barocas JA;  Colledge-Frisby S;  Treloar C;  Amin J;  Henderson C;  Read P;  Matthews GV;  Dunlop AJ;  Gorton C;  Hayllar J;  Alavi M;  Murray C;  Marks P;  Silk D;  Degenhardt L;  Dore GJ;  Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543
Carson JM;  Hajarizadeh B;  Hanson J;  O'Beirne J;  Iser D;  Read P;  Balcomb A;  Davies J;  Doyle JS;  Yee J;  Martinello M;  Marks P;  Matthews GV;  Dore GJ;  Post J;  Batey R;  Smart J;  Dawson O;  Hill S;  Douglas M;  Montebello M;  Collie P;  Hallinan R;  Snelgar G;  Baker D;  Galhenage S;  Soo TM;  Bopage R;  Faros J;  Cooper L;  Nelson R;  Shaw D;  Wilson M;  Pratt W;  Hinton S;  Wade A;  Van Gessel H;  Davidson L;  Dibdin M;  Lucas M;  Ahmad R;  Smith D;  Tan K;  Roder C;  Harney B;  Holdaway S;  Walsh J;  Fox P;  Mousavi R;  Lam W;  Dahal RP;  Habel P;  Gilliver R;  Silins E;  Ackerman J;  Deacon R;  Hall E;  Everson A;  Stewart J;  Milner M;  Ferguson C;  Tate-Baker J;  Bradshaw J;  Duncan G;  Baluran G;  Watson B;  Hey C;  Hickey R;  Orme C;  Miczkova S, 2022, 'Retreatment for hepatitis C virus direct-acting antiviral therapy virological failure in primary and tertiary settings: The REACH-C cohort', Journal of Viral Hepatitis, 29,  pp. 661 - 676, http://dx.doi.org/10.1111/jvh.13705
Weld ED;  Astemborski J;  Kirk GD;  Sulkowski MS;  Katz S;  Rothman R;  Solomon SS;  Matthews GV;  Hsieh YH;  Verma M;  Traverso G;  Swindells S;  Owen A;  Feld J;  Flexner C;  Mehta SH;  Thomas DL, 2022, 'Preferences of Persons with or at Risk for Hepatitis C for Long-Acting Treatments', Clinical Infectious Diseases, 75,  pp. 3 - 10, http://dx.doi.org/10.1093/cid/ciab913
Hall SAL;  Burns GS;  Anagnostou D;  Vogrin S;  Sundararajan V;  Ratnam D;  Levy MT;  Lubel JS;  Nicoll A;  Strasser SI;  Sievert W;  Desmond PV;  Ngu MC;  Angus P;  Sinclair M;  Meredith C;  Matthews G;  Revill PA;  Jackson K;  Littlejohn M;  Bowden D;  Locarnini SA;  Visvanathan K;  Thompson A, 2022, 'Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels', Alimentary Pharmacology and Therapeutics, 56,  pp. 310 - 320, http://dx.doi.org/10.1111/apt.16968
He WQ;  Matthews GV;  Liu B, 2022, 'Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults', Digestive Diseases and Sciences, 67,  pp. 2600 - 2607, http://dx.doi.org/10.1007/s10620-021-07008-z
Aggarwal A;  Stella AO;  Walker G;  Akerman A;  Esneau C;  Milogiannakis V;  Burnett DL;  McAllery S;  Silva MR;  Lu Y;  Foster CSP;  Brilot F;  Pillay A;  Van Hal S;  Mathivanan V;  Fichter C;  Kindinger A;  Hoppe AC;  Munier ML;  Amatayakul-Chantler S;  Roth N;  Coppola G;  Symonds GP;  Schofield P;  Jackson J;  Lenthall H;  Henry JY;  Mazigi O;  Jäck HM;  Davenport MP;  Darley DR;  Matthews GV;  Khoury DS;  Cromer D;  Goodnow CC;  Christ D;  Robosa R;  Starck DJ;  Bartlett NW;  Rawlinson WD;  Kelleher AD;  Turville SG;  Ruiz Silva M, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7,  pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7
Hosseini-Hooshyar S;  Hajarizadeh B;  Bajis S;  Law M;  Janjua NZ;  Fierer DS;  Chromy D;  Rockstroh JK;  Martin TCS;  Ingiliz P;  Hung CC;  Dore GJ;  Martinello M;  Matthews GV, 2022, 'Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression', Lancet HIV, 9,  pp. e414 - e427, http://dx.doi.org/10.1016/S2352-3018(22)00077-7
Lubel JS;  Strasser SI;  Thompson AJ;  Cowie BC;  MacLachlan J;  Allard NL;  Holmes J;  Kemp WW;  Majumdar A;  Iser D;  Howell J;  Matthews GV, 2022, 'Australian consensus recommendations for the management of hepatitis B', Medical Journal of Australia, 216,  pp. 478 - 486, http://dx.doi.org/10.5694/mja2.51430
Harney BL;  Sacks-Davis R;  Van Santen DK;  Traeger M;  Wilkinson AL;  Asselin J;  El-Hayek C;  Fairley CK;  Roth N;  Bloch M;  Matthews G;  Donovan B;  Guy R;  Stoové M;  Hellard ME;  Doyle JS;  Bastian L;  Bateson D;  Bowden S;  Boyd M;  Callander D;  Carter A;  Cogle A;  Costello J;  Dimech W;  Dittmer J;  Ellard J;  Franklin L;  Kim J;  Mcgill S;  Nolan D;  Patel P;  Pendle S;  Polkinghorne V;  Nguyen L;  Nguyen T;  O'connor C;  Reed P;  Ryder N;  Selvey C;  Vickers T;  Walker M;  Watchirs-Smith L;  West M, 2022, 'The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019', Clinical Infectious Diseases, 74,  pp. 1804 - 1811, http://dx.doi.org/10.1093/cid/ciab720
Howe AYM;  Rodrigo C;  Cunningham EB;  Douglas MW;  Dietz J;  Grebely J;  Popping S;  Sfalcin JA;  Parczewski M;  Sarrazin C;  de Salazar A;  Fuentes A;  Sayan M;  Quer J;  Kjellin M;  Kileng H;  Mor O;  Lennerstrand J;  Fourati S;  Di Maio VC;  Chulanov V;  Pawlotsky JM;  Harrigan PR;  Ceccherini-Silberstein F;  Garcia F;  Martinello M;  Matthews G;  Fernando FF;  Esteban JI;  Müllhaupt B;  Wiesch JSZ;  Buggisch P;  Neumann-Haefelin C;  Berg T;  Berg CP;  Schattenberg JM;  Moreno C;  Stauber R;  Lloyd A;  Dore G;  Applegate T;  Ignacio J;  Garcia-Cehic D;  Gregori J;  Rodriguez-Frias F;  Rando A;  Gozlan Y;  Angelico M;  Andreoni M;  Babudieri S;  Bertoli A;  Cento V;  Coppola N;  Craxì A;  Paolucci S;  Parruti G;  Pasquazzi C;  Perno CF;  Teti E;  Vironet C;  Lannergård A;  Duberg AS;  Aleman S;  Gutteberg T;  Soulier A;  Gourgeon A;  Chevaliez S;  Pol S;  Carrat F;  Salmon D;  Kaiser R;  Knopes E;  Gomes P;  de Kneght R;  Rijnders B;  Poljak M;  Lunar M;  Usubillaga R;  Seguin_Devaux C;  Tay E;  Wilson C;  Wang DS;  George J;  Kok J;  Pérez AB;  Chueca N;  García-Deltoro M;  Martínez-Sapiña AM;  Lara-Pérez MM;  García-Bujalance S;  Aldámiz-Echevarría T;  Vera-Méndez FJ;  Pineda JA;  Casado M;  Pascasio JM;  Salmerón J;  Alados-Arboledas JC;  Poyato A;  Téllez F;  Rivero-Juárez A, 2022, 'Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals', Jhep Reports, 4,  pp. 100462, http://dx.doi.org/10.1016/j.jhepr.2022.100462
Harnpariphan W;  Han WM;  Supanun R;  Ubolyam S;  Sophonphan J;  Ueaphongsukkit T;  Gatechompol S;  Tangkijvanich P;  Thanprasertsuk S;  Khwairakpam G;  Ruxrungthan K;  Phanuphak P;  Matthews GV;  Avihingsanon A, 2022, 'High Proportion of Blood-Borne and Sexually Transmitted Infections among People Deprived of Liberty in a Central Male Prison in Thailand: A Cross-Sectional Study 2018-2019', AIDS Research and Human Retroviruses, 38,  pp. 370 - 377, http://dx.doi.org/10.1089/aid.2021.0134
Back to profile page